Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.
Ng HS, Zhu F, Kingwell E, Yao S, Ekuma O, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H.
Ng HS, et al. Among authors: yao s.
Neurol Neuroimmunol Neuroinflamm. 2022 Jun 14;9(5):e200005. doi: 10.1212/NXI.0000000000200005. Print 2022 Sep.
Neurol Neuroimmunol Neuroinflamm. 2022.
PMID: 35701187
Free PMC article.